Professor Shankar Balasubramanian knighted
Congratulations to Professor Shankar Balasubramanian who has been named a Knight Bachelor for services to science and medicine.
He co-invented next generation sequencing which has provided one of the most transformative changes in biology and medicine for several decades, and has led to the $1000 dollar human genome. He has also made important contributions to four-stranded DNA, known as G-quadruplexes, and their role in cancer. Professor Balasubramanian is Herchel Smith Professor of Medicinal Chemistry in the Department of Chemistry the University of Cambridge, Senior Group Leader at the Cancer Research UK Cambridge Institute and Fellow of Trinity College.
It is a great honour for me and a wonderful acknowledgement of the research that I have carried out in Cambridge with my co-workers and collaborators over the past two decades. I was particularly pleased to see recognition of our basic science and its impact on medicine, as I am jointly appointed between the Departments of Chemistry and Medicine.
– Professor Sir Shankar Balasubramanian, Cancer Research UK Cambridge Institute
Related News
See all news-
World first trial to revolutionise treatment of brain cancer
23rd October 2024
A pioneering research study will trial multiple new treatments for people in the UK living with glioblastoma, an aggressive form of brain cancer.
Find out more -
Institute receives unprecedented £173M commitment from CRUK
15th October 2024
Cancer Research UK has announced a £173 million investment in the Cambridge Institute – the largest single grant ever awarded by the charity outside of London.
Find out more -
Madzia Crossley appointed as Junior Group Leader
1st October 2024
Dr Magdalena (Madzia) Crossley will be joining the Cancer Research UK Cambridge Institute as a Junior Group Leader starting in early 2025.
Find out more